尿素通过诱导铁灭菌来抑制肝细胞癌细胞的发展
Liuliu Zi1,2, Wangbin Ma1, Lilong Zhang1
1Department of Hepatobiliary and Laparoscopic Surgery, Renmin Hospital of Wuhan University, No. 238, Jiefang Road, Wuchang District, Wuhan 430060, China.
Journal of clinical medicine
|May 27, 2023
概括
尿液水平在肝细胞癌 (HCC) 组织中发生变化. 补充尿素通过激活ferroptosis来抑制HCC细胞的增殖和迁移,这表明其具有治疗潜力.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢学 代谢学 代谢学
背景情况:
- 尿素是DNA,RNA和葡萄糖合成的重要代谢物,主要在肝脏中产生.
- 尿素在肝细胞癌 (HCC) 瘤微环境中的作用及其治疗潜力仍然未被探索.
- 改变尿素代谢可能有助于HCC的发展和进展.
研究的目的:
- 为了研究HCC组织中的尿素水平.
- 探索尿素在HCC中的治疗疗效.
- 阐明尿素抗癌作用的潜在机制.
主要方法:
- 在HCC组织中使用组织微阵列 (n=115) 进行de novo尿素合成酶 (CAD,DHODH) 的基因表达分析.
- 通过LC-MS/MS (n=46) 来量化HCC和相邻非瘤组织中的尿素含量.
- 在体外和体内实验中评估尿素对HCC细胞增殖,入侵和迁移的影响.
主要成果:
- 在HCC组织中观察到CAD和DHODH的表达升高,而不是瘤组织.
- 在HCC组织中检测到明显较低的尿素含量 (484.22nmol/g) 与非瘤组织 (640.36nmol/g) 相比.
- 尿素的剂量依赖,通过激活铁亡途径来抑制HCC细胞的增殖,入侵和迁移.
结论:
- 在HCC中尿液代谢受到干扰,瘤组织中的水平降低.
- 尿素通过诱导铁亡来表现出对HCC的抗癌特性.
- 尿素代表了肝细胞癌的一个有前途的新型治疗标.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
08:37Use of the Pyrimidine Analog, 5-Iodo-2′-Deoxyuridine IdU with Cell Cycle Markers to Establish Cell Cycle Phases in a Mass Cytometry Platform
Published on: October 22, 2021
3.0K
相关概念视频
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
